Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results